RecruitingNCT04837352
Therapeutic Adherence of Multiple Sclerosis Patients
Obstacles and Levers of the Therapeutic Adherence of Multiple Sclerosis Patients
Sponsor
Lille Catholic University
Enrollment
153 participants
Start Date
Jan 18, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients. This study will provide a better understanding of the socio-psychological issues associated with different types of non-adherence to treatment, and identify the risk factors and vulnerability of each patient.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Multiple sclerosis defined according to McDonald criteria;
- Already undergone or beginning substantive treatment (self-managed, excluding treatment administered in hospital)
- Aged ≥ 18 years;
- Given the informed consent form.
Exclusion Criteria3
- Severe cognitive impairment (score below the 5th percentile);
- Any associated neurological pathology or serious or chronic somatic disease (cancer);
- Being under a legal protection measure.
Interventions
OTHERStudy of the role of sociocognitive factors
Questionnaires
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04837352
Related Trials
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT048734921 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT074776392 locations
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
NCT072253611 location